Übersicht der SEO Analyse
Metaangaben
80% 
Seitenqualität
68% 
Seitenstruktur
79% 
Verlinkung
25% 
Server
100% 
Externe Faktoren
100% 
SEO Score
Antwortzeit
0,20 s
Dateigröße
166,90 kB
Wörter
1229
Medien
21
Anzahl Links
374 Intern / 11 Extern

To-do Liste mit SEO Optimierungen

Meta-Angaben im HTML

Titel
(Extrem wichtig)
Novartis
Der Titel ist zu kurz. (76 Pixel von maximal 580 Pixel Länge) Jetzt optimieren
Der Seitentitel besteht nur aus einem Wort.
Es gibt keine Wortwiederholungen im Titel.
Meta-Description
(Extrem wichtig)
Working together, we can reimagine medicine to improve and extend people’s lives.
Die Meta-Description hat eine optimale Länge. (515 Pixel von maximal 1000 Pixel Länge)
Crawlbarkeit
(Extrem wichtig)
Es gibt keine Probleme beim Zugriff auf die Webseite.
Canonical Link
(Wichtig)
https://www.novartis.com/
Die Seite hat einen korrekten Canonical Link.
Sprache
(Wenig wichtig)
Im Text erkannte Sprache: en
Im HTML angegebene Sprache: en
Serverstandort: Vereinigte Staaten von Amerika
Die Sprache wird im HTML Code wie folgt angegeben: en
Alternate/Hreflang Links
(Wenig wichtig)
Die angegebenen Alternate Links sind fehlerfrei.
Weitere Metatags
(Wenig wichtig)
Es gibt keinen rel next Meta Tag auf der Seite.
Es gibt keinen rel prev Meta Tag auf der Seite.
Domain
(Wenig wichtig)
Die Domain ist keine Subdomain.
Die Länge der Domain ist gut.
Die Domain enthält keine Umlaute.
Seiten URL
(Wenig wichtig)
In der URL wurden keine Parameter entdeckt.
In der URL wurde keine Session ID entdeckt.
Die URL hat nicht zu viele Unterverzeichnisse.
Zeichensatzkodierung
(Wenig wichtig)
Die Angaben zur Zeichensatzkodierung (UTF-8) sind fehlerfrei.
Doctype
(Nice to have)
Die Doctype Angabe HTML 5 ist korrekt angegeben.
Die Doctype Angabe befindet sich an erster Stelle im HTML-Code.
Favicon
(Nice to have)
Das Favoriten Icon (Favicon) ist korrekt verlinkt.

Meta Tags

NameWert
descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
abstractWorking together, we can reimagine medicine to improve and extend people’s lives.
google-site-verificationLeer
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langen
twitter:cardsummary_large_image
twitter:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
twitter:site@novartis
twitter:titleNovartis
twitter:site:id17226612
twitter:creator@novartis
twitter:creator:id17226612
twitter:urlhttps://www.novartis.com/home
twitter:imagehttps://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg
twitter:image:altNovartis logo
og:site_nameNovartis
og:typeWebsite
og:urlhttps://www.novartis.com/home
og:titleNovartis
og:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
og:imagehttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:secure_urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:altNovartis logo
x-ua-compatibleie=edge
charsetutf-8

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von novartis.com!

Kostenlos Testen
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich

Seitenqualität

Inhalt
(Extrem wichtig)
Wörter aus der H1 Überschrift werden nicht im Text der Seite verwendet.
Der Inhalt ist mit 1229 Wörtern in Ordnung.
Der Text besteht zu 15.2% aus Füllwörtern.
Im Text befindet sich eine Aufzählung, dies deutet auf eine gute Textstruktur hin.
Es wurden 12 Fließtextblöcke auf der Seite gefunden.
Es wurden keine Platzhalter Texte bzw. Bilder gefunden.
Es befinden sich keine Duplikate auf der Seite.
Die durchschnittliche Satzlänge ist mit 12.4 Wörtern gut.
Frames
(Extrem wichtig)
Die Seite hat kein Frameset.
Mobile
(Wenig wichtig)
Es ist kein Apple-Touch Icon angegeben.
Der angegebene Viewport (width=device-width, initial-scale=1, shrink-to-fit=no) ist korrekt.
Bold- und Strongtags
(Wenig wichtig)
Die Menge an Tags ist mit 129 sehr hoch. Wir empfehlen für diese Webseite die Verwendung von maximal 25 Tags.
Einige Tags werden wiederholt. z.B.: international
Bilder Optimierung
(Wenig wichtig)
Alle gefundenen Bilder haben Alt-Attribute. (Alternativer Bild Text)
Soziale Vernetzung
(Nice to have)
Es befinden sich wenige Social-Sharing Möglichkeiten auf der Seite. Mit Plugins zum Teilen kann die Reichweite der Seite in sozialen Netzwerken erhöht werden.
Zusätzliches Markup
(Nice to have)
Es wurde kein zusätzliches Markup gefunden.
HTTPS
(Wenig wichtig)
Die Seite verwendet HTTPS um Daten sicher zu übertragen.
Alle eingebundenen Dateien werden ebenfalls über HTTPS ausgeliefert.

Medienliste

URLALT-AttributeTitel
/themes/custom/polaris/logo.svgNovartisHome
.../polaris/patterns/images/icon-search.svgOpen
...m/polaris/patterns/images/icon-close.svgClose
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...bed-kid-room-menu.jpg.webp?itok=KmIUz5U9Mother and daughter cuddling on a bed in a kids roomMother and daughter cuddling on a bed in a kids room
...ench-in-park-menu.jpg.webp?itok=5-8i5oYLAdult daughter talking to her senior parents on a bench in a parkAdult daughter talking to her senior parents on a bench in a park
...ood-pressure-menu.jpg.webp?itok=U5l7-GOFSmiling HCP taking senior patient's blood pressureSmiling HCP taking senior patient's blood pressure
...ientist-cambridge.jpg.webp?itok=_1WeOYMUA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...and-laughing-menu.jpg.webp?itok=fokSGWttGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...ptop-on-sofa-menu.jpg.webp?itok=ipyWZ-o1Business woman working on her laptop in a bright atmosphereBusiness woman working on her laptop in a bright atmosphere
...11/news-hero-menu.jpg.webp?itok=STu25KS9Overhead view of a meeting room with people in the foreground and screens in the backgroundOverhead view of a meeting room with people in the foreground and screens in the background
...-people-mega-menu.jpg.webp?itok=hwenfnKhTwo business peopleTwo business people
...ing-on-beach-menu.jpg.webp?itok=xtSMUGvgGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...laughing-on-beach.jpg.webp?itok=djN62APVGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...hess-and-laughing.jpg.webp?itok=qlEDLubbTwo men, seated indoors around a table, engaged in a conversation and playing chessTwo men, seated indoors around a table, engaged in a conversation and playing chess
...ientist-cambridge.jpg.webp?itok=XGxCz1arA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...ling-and-laughing.jpg.webp?itok=wVBQo2cDGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...024-media-content.jpg.webp?itok=yJUFkjIVQ2 2024Q2 2024
...r-father-new-york.jpg.webp?itok=kGsAkDwDShanelle Gabriel spending time with her father in New YorkShanelle Gabriel spending time with her father in New York
...s-people-laughing.jpg.webp?itok=xyS0mD6NThree business people laughingThree business people laughing

Seitenstruktur

H1 Überschrift
(Extrem wichtig)
Reimagining medicine, together
Die H1-Überschrift ist perfekt.
Überschriften
(Wichtig)
Die Überschriftenstruktur ist fehlerhaft. Es sollte keine Hierarchie (H1-H6) ausgelassen werden.

Überschriftenstruktur

Überschriften HierarchieInhalt
H1 Reimagining medicine, together
H2 Novartis Financial Results – Q2 2024
H2 Latest news
H2 Novartis in Society Integrated Report 2023
H2 Welcome to where we thrive together
H2 Resource links
H2 Novartis
H3 Discover our medicines
H3 Explore our science
H3 Learn about our impact
H3 Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk
H3 Novartis statement on Maximum Fair Price for Entresto
H3 Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)
H6 Working together
H6 Topics
H6 Explore
H6 Therapeutic areas
H6 Footer Bottom
Einige der Linktexte der internen Links sind zu lang.
Einige der Linktexte wiederholen sich.
Die Anzahl an internen Links ist ok.
Alle internen Links haben keine dynamischen Parameter.
Es befinden sich 11 externe Links auf der Seite.
LinkAttributeLinktext
https://www.novartis.com/Anchor Skip to main content
https://www.novartis.com/IMG-ALT Novartis
https://www.novartis.com/Anchor International
https://www.novartis.com/Anchor Americas
https://www.novartis.com/Anchor Asia Pacific
https://www.novartis.com/Anchor Europe
https://www.novartis.com/Anchor Middle East & Africa
https://www.novartis.com/Subdomain Global | English
https://www.novartisfoundation...Extern Subdomain Novartis Foundation | English
https://www.novartis.com/ar-es/Subdomain Argentina | Español
https://www.novartis.com/br-pt/Subdomain Brazil | Português
https://www.novartis.com/ca-en/Subdomain Canada | English
https://www.novartis.com/ca-fr/Subdomain Canada | Français
/candean-es/Subdomain Central America | Español
https://www.novartis.com/co-es/Subdomain Colombia | Español
https://www.novartis.com/mx-es/Subdomain Mexico | Español
https://www.novartis.com/us-en/Subdomain United States | English
https://www.novartis.com/au-en/Subdomain Australia | English
https://www.novartis.com/bd-en/Subdomain Bangladesh | English
https://www.novartis.com/hk-zh/Subdomain Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/in-en/Subdomain India | English
https://www.novartis.com/id-en/Subdomain Indonesia | English
https://www.novartis.com/jp-ja/Subdomain Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Korea | 한국어
https://www.novartis.com.cn/Extern Subdomain Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Malaysia | English
https://www.novartis.com/pk-en/Subdomain Pakistan | English
https://www.novartis.com/ph-en/Subdomain Philippines | English
https://www.novartis.com/sg-en/Subdomain Singapore | English
https://www.novartis.com/tw-zh/Subdomain Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Thailand | ภาษาไทย
https://www.novartis.com/at-de/Subdomain Austria | Deutsch
https://www.novartis.com/be-fr/Subdomain Belgium | Français
https://www.novartis.com/be-nl/Subdomain Belgium | Nederlands
https://www.novartis.com/bg-bg/Subdomain Bulgaria | Български
https://www.novartis.com/cz-cs/Subdomain Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Denmark | Dansk
https://www.novartis.com/ee-et/Subdomain Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain France | Français
https://www.novartis.com/de-de/Subdomain Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Greece | Ελληνικά
https://www.novartis.com/hu-hu/Subdomain Hungary | Magyar
https://www.novartis.com/ie-en/Subdomain Ireland | English
https://www.novartis.com/it-it/Subdomain Italy | Italiano
https://www.novartis.com/lv-lv/Subdomain Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Lithuania | Lithuanian
https://www.novartis.com/nl-nl/Subdomain Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Norway | Norsk
https://www.novartis.com/pl-pl/Subdomain Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Romania | Română
https://www.novartis.com/ru-ru/Subdomain Russia | Русский
https://www.novartis.com/rs-sr/Subdomain Serbia | Srpski
https://www.novartis.com/sk-sk/Subdomain Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Slovenia | English
https://www.novartis.com/es-es/Subdomain Spain | Español
https://www.novartis.com/se-se/Subdomain Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Switzerland | Français
https://www.novartis.com/tr-tr/Subdomain Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain United Kingdom | English
https://www.novartis.com/eg-en/Subdomain Egypt | English
https://www.novartis.com/il-he/Subdomain Israel | עברית
https://www.novartis.com/sa-ar/Subdomain Saudi Arabia | العربية
https://www.novartis.com/za-en/Subdomain South Africa | English
https://www.novartis.com/Anchor Textduplikat International
https://www.novartis.com/Anchor Textduplikat Americas
https://www.novartis.com/Anchor Textduplikat Asia Pacific
https://www.novartis.com/Anchor Textduplikat Europe
https://www.novartis.com/Anchor Textduplikat Middle East & Africa
https://www.novartis.com/ar-es/Subdomain Textduplikat Argentina | Español
https://www.novartis.com/au-en/Subdomain Textduplikat Australia | English
https://www.novartis.com/at-de/Subdomain Textduplikat Austria | Deutsch
https://www.novartis.com/bd-en/Subdomain Textduplikat Bangladesh | English
https://www.novartis.com/be-fr/Subdomain Textduplikat Belgium | Français
https://www.novartis.com/be-nl/Subdomain Textduplikat Belgium | Nederlands
https://www.novartis.com/br-pt/Subdomain Textduplikat Brazil | Português
https://www.novartis.com/bg-bg/Subdomain Textduplikat Bulgaria | Български
https://www.novartis.com/ca-en/Subdomain Textduplikat Canada | English
https://www.novartis.com/ca-fr/Subdomain Textduplikat Canada | Français
/candean-es/Subdomain Textduplikat Central America | Español
https://www.novartis.com/co-es/Subdomain Textduplikat Colombia | Español
https://www.novartis.com/cz-cs/Subdomain Textduplikat Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Textduplikat Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Textduplikat Denmark | Dansk
https://www.novartis.com/eg-en/Subdomain Textduplikat Egypt | English
https://www.novartis.com/ee-et/Subdomain Textduplikat Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Textduplikat Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain Textduplikat France | Français
https://www.novartis.com/de-de/Subdomain Textduplikat Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Textduplikat Greece | Ελληνικά
https://www.novartis.com/hk-zh/Subdomain Textduplikat Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/hu-hu/Subdomain Textduplikat Hungary | Magyar
https://www.novartis.com/in-en/Subdomain Textduplikat India | English
https://www.novartis.com/id-en/Subdomain Textduplikat Indonesia | English
https://www.novartis.com/ie-en/Subdomain Textduplikat Ireland | English
https://www.novartis.com/il-he/Subdomain Textduplikat Israel | עברית
https://www.novartis.com/it-it/Subdomain Textduplikat Italy | Italiano
https://www.novartis.com/jp-ja/Subdomain Textduplikat Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Textduplikat Korea | 한국어
https://www.novartis.com/lv-lv/Subdomain Textduplikat Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Textduplikat Lithuania | Lithuanian
https://www.novartis.com.cn/Extern Subdomain Textduplikat Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Textduplikat Malaysia | English
https://www.novartis.com/mx-es/Subdomain Textduplikat Mexico | Español
https://www.novartis.com/nl-nl/Subdomain Textduplikat Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Textduplikat Norway | Norsk
https://www.novartis.com/Subdomain Textduplikat Global | English
https://www.novartisfoundation...Extern Subdomain Textduplikat Novartis Foundation | English
https://www.novartis.com/pk-en/Subdomain Textduplikat Pakistan | English
https://www.novartis.com/ph-en/Subdomain Textduplikat Philippines | English
https://www.novartis.com/pl-pl/Subdomain Textduplikat Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Textduplikat Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Textduplikat Romania | Română
https://www.novartis.com/ru-ru/Subdomain Textduplikat Russia | Русский
https://www.novartis.com/sa-ar/Subdomain Textduplikat Saudi Arabia | العربية
https://www.novartis.com/rs-sr/Subdomain Textduplikat Serbia | Srpski
https://www.novartis.com/sg-en/Subdomain Textduplikat Singapore | English
https://www.novartis.com/sk-sk/Subdomain Textduplikat Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Textduplikat Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Textduplikat Slovenia | English
https://www.novartis.com/za-en/Subdomain Textduplikat South Africa | English
https://www.novartis.com/es-es/Subdomain Textduplikat Spain | Español
https://www.novartis.com/se-se/Subdomain Textduplikat Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Textduplikat Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Textduplikat Switzerland | Français
https://www.novartis.com/tw-zh/Subdomain Textduplikat Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Textduplikat Thailand | ภาษาไทย
https://www.novartis.com/tr-tr/Subdomain Textduplikat Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain Textduplikat United Kingdom | English
https://www.novartis.com/us-en/Subdomain Textduplikat United States | English
https://www.novartis.com/aboutAbout
A-TITLE About
/about/board-directorsBoard of Directors
A-TITLE Board of Directors
/about/board-directors/joerg-r...Joerg Reinhardt
A-TITLE Joerg Reinhardt
/about/board-directors/simon-m...Simon Moroney
A-TITLE Simon Moroney
/about/board-directors/nancy-c...Nancy C. Andrews
A-TITLE Nancy C. Andrews
/about/board-directors/ton-bue...Ton Buechner
A-TITLE Ton Buechner
/about/board-directors/patrice...Patrice Bula
A-TITLE Patrice Bula
/about/board-directors/elizabe...Elizabeth (Liz) Doherty
A-TITLE Elizabeth (Liz) Doherty
/about/board-directors/ana-de-...Ana de Pro Gonzalo
A-TITLE Ana de Pro Gonzalo
/about/board-directors/bridget...Bridgette Heller
A-TITLE Bridgette Heller
/about/board-directors/daniel-...Daniel Hochstrasser
A-TITLE Daniel Hochstrasser
/about/board-directors/frans-v...Frans van Houten
A-TITLE Frans van Houten
/about/board-directors/charles...Charles L. Sawyers
A-TITLE Charles L. Sawyers
/about/board-directors/william...William T. Winters
A-TITLE William T. Winters
/about/board-directors/john-d-...John D. Young
A-TITLE John D. Young
/about/board-directors/charlot...Charlotte Pamer-Wieser
A-TITLE Charlotte Pamer-Wieser
/about/executive-committeeExecutive Committee
A-TITLE Executive Committee
/about/executive-committee/vas...Vasant (Vas) Narasimhan
A-TITLE Vasant (Vas) Narasimhan
/about/executive-committee/shr...Shreeram Aradhye
A-TITLE Shreeram Aradhye
/about/executive-committee/vic...Victor Bulto
A-TITLE Victor Bulto
/about/executive-committee/aha...Aharon (Ronny) Gal
A-TITLE Aharon (Ronny) Gal
/about/executive-committee/kar...Karen L. Hale
A-TITLE Karen L. Hale
/about/executive-committee/pat...Patrick Horber
A-TITLE Patrick Horber
/about/executive-committee/har...Harry Kirsch
A-TITLE Harry Kirsch
/about/executive-committee/rob...Rob Kowalski
A-TITLE Rob Kowalski
/about/executive-committee/ste...Steffen Lang
A-TITLE Steffen Lang
/about/executive-committee/fio...Fiona Marshall
A-TITLE Fiona Marshall
/about/executive-committee/kla...Klaus Moosmayer
A-TITLE Klaus Moosmayer
/about/executive-committee/lut...Lutz Hegemann
A-TITLE Lutz Hegemann
/about/executive-committee/kee...Kees Roks
A-TITLE Kees Roks
/about/executive-committee/mic...Michelle Weese
A-TITLE Michelle Weese
/about/productsProducts
A-TITLE Products
/about/therapeutic-areasTherapeutic areas
A-TITLE Therapeutic areas
/about/therapeutic-areas/cardi...Cardiovascular, renal and metabolic
A-TITLE Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Immunology
A-TITLE Immunology
/about/therapeutic-areas/neuro...Neuroscience
A-TITLE Neuroscience
/about/therapeutic-areas/oncologyOncology
A-TITLE Oncology
/about/people-and-culturePeople and culture
A-TITLE People and culture
/about/diversity-equity-and-in...Diversity, equity and inclusion
A-TITLE Diversity, equity and inclusion
/about/diversity-equity-and-in...Equity
A-TITLE Equity
/about/diversity-equity-inclus...Inclusivity
A-TITLE Inclusivity
/about/diversity-equity-and-in...Parental leave
A-TITLE Parental leave
/about/diversity-equity-inclus...Society
A-TITLE Society
/about/novartis-gene-therapiesNovartis Gene Therapies
A-TITLE Novartis Gene Therapies
/about/manufacturingManufacturing
A-TITLE Manufacturing
/about/qualityQuality
A-TITLE Quality
/about/quality/audit-programAudit program
A-TITLE Audit program
/about/quality/novartis-qualit...Novartis quality management system (QMS)
A-TITLE Novartis quality management system (QMS)
/about/quality/product-and-pat...Product and patient safety training
A-TITLE Product and patient safety training
/about/quality/regulatory-insp...Regulatory inspections
A-TITLE Regulatory inspections
/about/quality/product-recallsProduct recalls
A-TITLE Product recalls
/about/quality/third-party-sup...Third-party suppliers
A-TITLE Third-party suppliers
/about/awards-and-recognitionAwards and recognition
A-TITLE Awards and recognition
https://www.novartis.com/aboutIMG-ALT Mother and daughter cuddling on a bed in a kids room
https://www.novartis.com/aboutTextduplikat About
https://www.novartis.com/aboutNovartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare profe...
/patients-and-caregiversPatients and caregivers
A-TITLE Patients and caregivers
/patients-and-caregivers/novar...Novartis commitment to patients and caregivers
A-TITLE Novartis commitment to patients and caregivers
https://www.novartis.com/diseasesDiseases
A-TITLE Diseases
/investors/reporting-and-trans...Patient organization funding
A-TITLE Patient organization funding
/news/stories/patient-perspect...Patients perspectives stories
A-TITLE Patients perspectives stories
/patients-and-caregiversIMG-ALT Adult daughter talking to her senior parents on a bench in a park
/patients-and-caregiversTextduplikat Patients and caregivers
/patients-and-caregiversInformation for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations a...
/healthcare-professionalsHealthcare professionals
A-TITLE Healthcare professionals
/healthcare-professionals/medi...Medical congresses and events
A-TITLE Medical congresses and events
/healthcare-professionals/medi...ASCO Annual Meeting
A-TITLE ASCO Annual Meeting
/about/productsTextduplikat Products
A-TITLE Products
/research-development/novartis...Novartis pipeline
A-TITLE Novartis pipeline
/healthcare-professionals/mana...Managed access programs
A-TITLE Managed access programs
/healthcare-professionals/mana...Zolgensma® Global Managed Access Program (gMAP)
A-TITLE Zolgensma® Global Managed Access Program (gMAP)
/healthcare-professionals/nova...Novartis external funding
A-TITLE Novartis external funding
/healthcare-professionals/heal...Healthcare professional resources by country
A-TITLE Healthcare professional resources by country
/healthcare-professionals/inve...Investigator-initiated trials / studies
A-TITLE Investigator-initiated trials / studies
/healthcare-professionals/nova...Novartis medical information
A-TITLE Novartis medical information
/healthcare-professionals/nova...Submit medical enquiry
A-TITLE Submit medical enquiry
/healthcare-professionalsIMG-ALT Smiling HCP taking senior patient's blood pressure
/healthcare-professionalsTextduplikat Healthcare professionals
/healthcare-professionalsResources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
/research-and-developmentResearch and development
A-TITLE Research and development
/research-and-development/tech...Technology platforms
A-TITLE Technology platforms
/research-and-development/rese...Research disease areas
A-TITLE Research disease areas
/research-and-development/rese...Cardiovascular and metabolic disease research at Novartis
A-TITLE Cardiovascular and metabolic disease research at Novartis
/research-and-development/rese...DAx: exploratory disease research at Novartis
A-TITLE DAx: exploratory disease research at Novartis
/research-and-development/rese...Global Health disease area research at Novartis
A-TITLE Global Health disease area research at Novartis
/research-and-development/rese...Immunology disease research at Novartis
A-TITLE Immunology disease research at Novartis
/research-and-development/rese...Neuroscience research at Novartis
A-TITLE Neuroscience research at Novartis
/research-and-development/rese...Oncology research at Novartis
A-TITLE Oncology research at Novartis
/research-and-development/rese...Ophthalmology research at Novartis
A-TITLE Ophthalmology research at Novartis
/research-development/novartis...Textduplikat Novartis pipeline
A-TITLE Novartis pipeline
/research-and-development/rese...Research collaborations
A-TITLE Research collaborations
/research-development/collabor...Collaborations
A-TITLE Collaborations
/research-and-developmentIMG-ALT A female research scientist in a lab looking at a sample
/research-and-developmentResearch & development
/research-and-developmentDiscover how Novartis turns breakthrough science into transformative, high-value treatments.
https://www.novartis.com/esgESG
A-TITLE ESG
/esg/accessAccess
A-TITLE Access
/esg/access/creating-sustainab...Creating sustainable business models
A-TITLE Creating sustainable business models
/esg/access/value-based-pricingValue-based pricing
A-TITLE Value-based pricing
/esg/access/sub-saharan-africaSub-Saharan Africa
A-TITLE Sub-Saharan Africa
/esg/access/donationsDonations
A-TITLE Donations
/esg/access/novartis-access-pr...Novartis access principles
A-TITLE Novartis access principles
/esg/access/novartis-oncology-...Novartis oncology access
A-TITLE Novartis oncology access
/esg/access/patents-and-licensingPatents and licensing
A-TITLE Patents and licensing
/esg/environmental-sustainabilityEnvironmental sustainability
A-TITLE Environmental sustainability
/esg/environmental-sustainabil...Climate
A-TITLE Climate
/esg/environmental-sustainabil...Waste
A-TITLE Waste
/esg/environmental-sustainabil...Water
A-TITLE Water
/esg/ethics-risk-and-complianceEthics, risk and compliance
A-TITLE Ethics, risk and compliance
/esg/ethics-risk-and-complianc...Ethical behavior
A-TITLE Ethical behavior
/esg/ethics-risk-and-complianc...Compliance
A-TITLE Compliance
/esg/ethics-risk-and-complianc...Human rights
A-TITLE Human rights
/esg/ethics-risk-and-complianc...Learning and engagement
A-TITLE Learning and engagement
/esg/ethics-risk-and-complianc...Risk management
A-TITLE Risk management
/esg/global-healthGlobal health
A-TITLE Global health
/esg/global-health/pandemic-pr...Pandemic preparedness
A-TITLE Pandemic preparedness
/esg/global-health/avoidable-b...Avoidable blindness
A-TITLE Avoidable blindness
/diseases/chagas-diseaseChagas disease
A-TITLE Chagas disease
/diseases/leprosyLeprosy
A-TITLE Leprosy
/diseases/malariaMalaria
A-TITLE Malaria
/diseases/sickle-cell-diseaseSickle cell disease (SCD)
A-TITLE Sickle cell disease (SCD)
https://www.novartisfoundation...Neues Fenster Extern Subdomain Novartis Foundation
A-TITLE Novartis Foundation
/about/diversity-equity-and-in...Textduplikat Diversity, equity and inclusion
A-TITLE Diversity, equity and inclusion
/esg/indexESG index
A-TITLE ESG index
/investors/reporting-and-trans...Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Novartis in Society Integrated Report
A-TITLE Novartis in Society Integrated Report
/investors/reporting-and-trans...ESG rating performance
A-TITLE ESG rating performance
/investors/reporting-and-trans...Targets
A-TITLE Targets
/investors/reporting-and-trans...Textduplikat Patient organization funding
A-TITLE Patient organization funding
/investors/reporting-and-trans...Payments to healthcare professionals
A-TITLE Payments to healthcare professionals
/investors/reporting-and-trans...Public policy
A-TITLE Public policy
/investors/reporting-and-trans...A living wage
A-TITLE A living wage
/investors/reporting-and-trans...A safe workplace
A-TITLE A safe workplace
/investors/reporting-and-trans...Animal research
A-TITLE Animal research
https://www.novartis.com/esgIMG-ALT Group of warm clothed women, seated outside, smiling and laughing
https://www.novartis.com/esgEnvironmental, social and governance
https://www.novartis.com/esgLearn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding h...
/investorsInvestors
A-TITLE Investors
/investors/event-calendarEvent calendar
A-TITLE Event calendar
/investors/financial-dataFinancial data
A-TITLE Financial data
/investors/financial-data/annu...Novartis annual results
A-TITLE Novartis annual results
/investors/financial-data/quar...Novartis quarterly results
A-TITLE Novartis quarterly results
/investors/financial-data/sec-...Novartis SEC filings
A-TITLE Novartis SEC filings
/investors/financial-data/prod...Product sales
A-TITLE Product sales
/investors/financial-data/fixe...Fixed-income securities
A-TITLE Fixed-income securities
/investors/financial-data/expe...Expected currency impact
A-TITLE Expected currency impact
/investors/share-data-analysisShare data and analysis
A-TITLE Share data and analysis
/investors/share-data-analysis...Share monitor
A-TITLE Share monitor
/investors/share-data-and-anal...Dividend information
A-TITLE Dividend information
/investors/share-data-analysis...Share ownership
A-TITLE Share ownership
/investors/share-data-analysis...Share overview
A-TITLE Share overview
/investors/share-data-analysis...Return on investment calculator
A-TITLE Return on investment calculator
/investors/shareholder-informa...Shareholder information
A-TITLE Shareholder information
/investors/shareholder-informa...General Meetings
A-TITLE General Meetings
/investors/shareholder-informa...American Depositary Receipts (ADR)
A-TITLE American Depositary Receipts (ADR)
/investors/shareholder-informa...Share buyback
A-TITLE Share buyback
/investors/shareholder-informa...Frequently asked questions
A-TITLE Frequently asked questions
/investors/company-overviewCompany overview
A-TITLE Company overview
/investors/company-overview/co...Corporate governance
A-TITLE Corporate governance
/investors/reporting-and-trans...Textduplikat Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Textduplikat Novartis in Society Integrated Report
A-TITLE Novartis in Society Integrated Report
/investors/reporting-and-trans...Reporting archive
A-TITLE Reporting archive
/investors/reporting-and-trans...Textduplikat ESG rating performance
A-TITLE ESG rating performance
/news/stay-up-to-datePublications order form
A-TITLE Publications order form
https://www.novartis.com/esgTextduplikat ESG
A-TITLE ESG
/investorsIMG-ALT Business woman working on her laptop in a bright atmosphere
/investorsTextduplikat Investors
/investorsUpdates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
https://www.novartis.com/newsNews
A-TITLE News
/news/news-archiveNews archive
A-TITLE News archive
/news/media-libraryMedia library
A-TITLE Media library
https://www.novartis.com/storiesStories
A-TITLE Stories
/news/stay-up-to-dateSubscribe
A-TITLE Subscribe
https://www.novartis.com/newsIMG-ALT Overhead view of a meeting room with people in the foreground and screens in the background
https://www.novartis.com/newsTextduplikat News
https://www.novartis.com/newsInformation for journalists including media releases, statements, stories, multimedia resources and more.
https://www.novartis.com/careersCareers
A-TITLE Careers
/careers/career-searchCareer search
A-TITLE Career search
/careers/our-business-functionsOur business functions
A-TITLE Our business functions
/careers/our-business-function...Careers in research and development
A-TITLE Careers in research and development
/careers/our-business-function...Careers in operations
A-TITLE Careers in operations
/careers/our-business-function...Careers in commercial and sales
A-TITLE Careers in commercial and sales
/careers/our-business-function...Careers in global functions
A-TITLE Careers in global functions
/careers/why-novartisWhy Novartis
A-TITLE Why Novartis
/careers/career-hubCareer hub
A-TITLE Career hub
https://novartis.willhire.co/Neues Fenster Extern Subdomain Temporary contracts
A-TITLE Temporary contracts
/careers/early-careersEarly careers
A-TITLE Early careers
/careers/early-careers/graduatesGraduates
A-TITLE Graduates
/careers/early-careers/studentsStudents
A-TITLE Students
/careers/early-careers/us-biom...US Biomedical Research internship programs
A-TITLE US Biomedical Research internship programs
/careers/early-careers/communi...Community exploration and learning lab (CELL)
A-TITLE Community exploration and learning lab (CELL)
https://www.novartis.com/careersIMG-ALT Two business people
https://www.novartis.com/careersTextduplikat Careers
https://www.novartis.com/careersNovartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
/clinicaltrialsClinical trials
A-TITLE Clinical trials
/partneringPartnering
A-TITLE Partnering
/supplier-portalSupplier portal
A-TITLE Supplier portal
https://www.novartis.com/reportNeues Fenster Report side effects
A-TITLE Report side effects
https://www.novartis.com/contactsContacts
A-TITLE Contacts
https://www.novartis.com/homeIMG-ALT Grandmother, mother and daughter smiling and laughing on a beach
https://www.novartis.com/homeHome
https://www.novartis.com/homeWorking together, we can reimagine medicine to improve and extend people’s lives.
/about/therapeutic-areasDiscover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
IMG-ALT Two men, seated indoors around a table, engaged in a conversation and playing chess
/research-and-developmentExplore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
IMG-ALT A female research scientist in a lab looking at a sample
/news/novartis-financial-resul...Learn more
A-TITLE Learn more
/news/media-releases/novartis-...Aug 28, 2024 Media Release Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in pa...
/news/novartis-statement-maxim...Aug 15, 2024 Statement Novartis statement on Maximum Fair Price for Entresto
/news/media-releases/novartis-...Aug 08, 2024 Media Release Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of...
/news/news-archiveAll news
A-TITLE All news
/investors/reporting-and-trans...View the online summary
A-TITLE View the online summary
https://www.novartis.com/careersWelcome to where we thrive together
A-TITLE Welcome to where we thrive together
https://www.novartis.com/careersJoin us
A-TITLE Join us
https://www.novartis.com/aboutAbout Novartis
A-TITLE About Novartis
/healthcare-professionalsTextduplikat Healthcare professionals
A-TITLE Healthcare professionals
/patients-and-caregiversTextduplikat Patients and caregivers
A-TITLE Patients and caregivers
/research-development/novartis...Pipeline
A-TITLE Pipeline
/about/productsTextduplikat Products
A-TITLE Products
/patients-and-caregiversTextduplikat Patients and caregivers
/healthcare-professionalsTextduplikat Healthcare professionals
/research-and-developmentResearchers
https://www.novartis.com/careersJob seekers
https://www.novartis.com/newsJournalists
/investorsTextduplikat Investors
/news/novartis-financial-resul...Q2 2024
/esg/accessTextduplikat Access
/about/diversity-equity-and-in...Diversity
https://www.novartis.com/esgTextduplikat ESG
/esg/ethics-risk-and-complianc...SpeakUp
/research-development/novartis...Textduplikat Pipeline
/about/productsTextduplikat Products
/clinicaltrialsTextduplikat Clinical trials
/partneringTextduplikat Partnering
https://www.novartis.com/storiesTextduplikat Stories
/about/therapeutic-areas/cardi...Textduplikat Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Textduplikat Immunology
/about/therapeutic-areas/neuro...Textduplikat Neuroscience
/about/therapeutic-areas/oncologyTextduplikat Oncology
https://www.linkedin.com/compa...Neues Fenster Extern Subdomain A-TITLE LinkedIn
https://www.facebook.com/novartisNeues Fenster Extern Subdomain A-TITLE Facebook
https://www.twitter.com/novartisNeues Fenster Extern Subdomain A-TITLE X formerly known as Twitter
https://www.instagram.com/nova...Neues Fenster Extern Subdomain A-TITLE Instagram
https://www.youtube.com/user/n...Neues Fenster Extern Subdomain A-TITLE Youtube
/terms-useTerms of use
https://www.novartis.com/privacyPrivacy
https://www.novartis.com/Anchor Cookie settings
https://www.novartis.com/contactsTextduplikat Contacts
/about/locationsLocations
/sitemap.xmlSite map
/open-sourceOpen source
/accessibilityWeb accessibility
/novartis-directoryNovartis Site Directory
A-TITLE Novartis Site Directory

Serverkonfiguration

HTTP-Weiterleitungen
(Extrem wichtig)
Die Seite leitet weiter auf "https://www.novartis.com/"
HTTP-Header
(Wichtig)
Es wird kein X-Powered HTTP-Header mitgesendet.
Der Webserver nutzt GZip zur komprimierten Übertragung der Webseite (HTML).
Performance
(Wenig wichtig)
Die Antwortzeit der HTML-Seite ist mit 0,20 Sekunden unter der Zielmarke von 0,40 Sekunden.
Die Dateigröße des HTML-Dokuments ist mit 167 kB in Ordnung.

HTTP-Header

NameWert
dateSun, 01 Sep 2024 18:51:19 GMT
content-typetext/html; charset=UTF-8
cache-controlpublic, max-age=300
content-languageen
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
expiresSun, 01 Sep 2024 18:56:19 GMT
last-modifiedSun, 01 Sep 2024 18:49:56 GMT
varyCookie,Accept-Encoding
content-security-policy-report-onlyscript-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js blob:; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com; frame-ancestors self; report-uri /report-csp-violation
x-xss-protection1; mode=block
strict-transport-securitymax-age=31536000; includeSubDomains
x-request-idv-fb73c2e6-6892-11ef-9fb1-4f1d900a5f3c
x-ah-environmentprod
age52
viavarnish
x-cacheHIT
x-cache-hits14
cf-cache-statusHIT
servercloudflare
cf-ray8bc773737fd43815-FRA
content-encodinggzip
statuscode200
http_versionHTTP/2

Externe Faktoren

Blacklists
(Nice to have)
Die Seite wird nicht als "nur für Erwachsene" eingestuft.
Die Seite wird von Wikipedia verlinkt.
Die Seite ist exzellent von anderen Webseiten verlinkt.
Die Seite hat Backlinks von 15.636 verweisenden Domains.
Die Seite hat insgesamt 1.343.029 Backlinks.
Die Seite hat Backlinks von 10.876 verschiedenen IP Adressen.
Verbreitung bei Facebook
(Wenig wichtig)
Die Seite hat 0 Shares und Kommentare auf Facebook.

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files

Disallow: /web.config
# Paths (clean URLs)

Disallow: /comment/reply/
Disallow: /filter/tips

Disallow: /search/




# Paths (no clean URLs)

Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips

Disallow: /index.php/search/




Disallow: /*printable
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /*/spc/*FAQ*
Disallow: /*/spc/*RMP*
Disallow: /*FAQ*
Disallow: /*RMP*

User-agent: GPTBot
Crawl-delay: 2

User-agent: bingbot
Crawl-delay: 2

User-agent: GoogleOther
Crawl-delay: 2

Suchvorschau

www.novartis.com
Novartis
Working together, we can reimagine medicine to improve and extend people’s lives.

Wichtigste Suchbegriffe

Folgende Keywords wurden erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.

KeywordErgebnisPrüfen
Novartis70%Check
medicine66%Check
reimagine medicine58%Check
Novartis Society55%Check
Working54%Check
Novartis Foundation53%Check
People52%Check
extend people49%Check
lives46%Check
reimagine46%Check

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von novartis.com!

Kostenlos Testen
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich

Cookie Einstellungen

Wir verwenden Cookies, damit unsere Website funktioniert und auch für Analyse- und Werbezwecke. Du kannst optionale Cookies selbstverständlich auch deaktivieren, siehe die folgenden Links für weitere Informationen.

Diese Cookies werden für grundlegende Websitefunktionen benötigt.

Damit wir besser verstehen, wie Besucher unsere Website nutzen.

Damit wir für Dich passgenaue Angebote bereitstellen können.